it will be interesting to see ebitda and npat numbers for these market darlings. Not sure those key numbers will justify the valuations. Growth means scale but can come at a cost to margins that is not always factored in.
If you look back ifl, they published big growth numbers but this did not turn into profit. Netwealth and hub may show similar results.
- Forums
- ASX - By Stock
- AMP
- AMP Valuations - up to $2.17
AMP Valuations - up to $2.17, page-113
Featured News
Add AMP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.50 |
Change
-0.003(0.17%) |
Mkt cap ! $3.810B |
Open | High | Low | Value | Volume |
$1.50 | $1.51 | $1.49 | $378.1K | 252.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 48704 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.51 | 16662 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 48306 | 1.500 |
12 | 200836 | 1.495 |
11 | 78015 | 1.490 |
9 | 112621 | 1.485 |
8 | 383549 | 1.480 |
Price($) | Vol. | No. |
---|---|---|
1.505 | 12463 | 12 |
1.510 | 94795 | 16 |
1.515 | 88590 | 9 |
1.520 | 135448 | 13 |
1.525 | 133735 | 12 |
Last trade - 10.33am 15/11/2024 (20 minute delay) ? |
Featured News
AMP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
Previous Video
Next Video
SPONSORED BY The Market Online